Insights on Discovery
-
Five Inverted-Microscope Advantages For Industrial Applications
1/4/2024
Learn about five of the advantages to using an inverted microscope for sample observation and industrial applications, as opposed to an upright microscope.
-
Lowering The Lipids Barrier: The Key To Accelerating RNA-LNP Drug Development
12/27/2023
Learn about the drug development hurdles that must be overcome to deliver on the promise of mRNA.
-
Optimized And Scalable LNP Composition For RNA Vaccine Delivery
12/20/2023
Explore results from a study screening novel LNP formulations for physicochemical attributes, in vitro potency, and in vivo immunogenicity in both SARS-CoV-2 and influenza vaccine applications.
-
State Of Validation
12/20/2023
CAI, Kneat Solutions, and others have partnered again in 2023 to conduct the annual State of Validation survey. Find out what the results of this year’s survey concluded.
-
3D Biology: The Paradigm Shift In Next-Generation Drug Discovery
12/13/2023
Learn how the transition to 3D biology is aiding scientists in their research and why the industry is embracing organoids for next-gen drug discovery.
-
Industrial-Scale Organoid Production: Challenges, Advantages And Solutions
12/12/2023
Organoids, 3D models replicating human organs, are a growing topic of interest for researchers as they offer invaluable advantages, but come with several challenges.
-
The Role Of CRISPR Cas9 Plasmids In Gene-Editing
12/12/2023
Plasmids are crucial for CRISPR-Cas9 gene-editing technology, and their role in CRISPR is expected to evolve with ongoing research.
-
Following The Science To Develop Best-In-Class Cancer Drugs
12/11/2023
As innovative cancer therapeutics continue to enter the clinical trial pipeline, some developers are shifting their focus towards developing drugs that are safe and efficacious with minimal toxicity.
-
A Lean, Agile Business Model To Deliver High-Quality Oncologic Treatments
12/11/2023
No two journeys through the drug pipeline are the same; the ability to leverage a variety of approaches for different products is what sets one lean biotech company apart.
-
A Tale Of Two Brothers: The Abpro Founders
12/11/2023
By founding their latest venture, Abpro, Ian and Eugene Chan are using their synergistic skillsets in business and medicine to rapidly generate antibodies that treat cancer and autoimmune diseases.